Targeted silencing of DEFB4 in a bioengineered skin-humanized mouse model for psoriasis: development of siRNA SECosome-based novel therapies-Reference-Cited by-同舟云学术

Targeted silencing of DEFB4 in a bioengineered skin-humanized mouse model for psoriasis: development of siRNA SECosome-based novel therapies

Published:2014-03 Issue:3 Volume:23 Page:199-201
ISSN:0906-6705
Container-title:Experimental Dermatology
language:en
Short-container-title:Exp Dermatol

Author:

Bracke Stefanie¹,Carretero Marta²³,Guerrero-Aspizua Sara³⁴,Desmet Eline¹,Illera Nuria³⁵,Navarro Manuel⁶,Lambert Jo¹,Del Rio Marcela³⁴

Affiliation:

1. Department of Dermatology; Ghent University Hospital; Ghent Belgium

2. Cutaneous Diseases Modeling Unit; Epithelial Biomedicine Division; Basic Research Department; Centro de Investigaciones Energéticas; Medioambientales y Tecnológicas (CIEMAT); Madrid Spain

3. Centre for Biomedical Research on Rare Diseases (CIBERER); ISCIII; Valencia Spain

4. Department of Bioengineering; Carlos III University (UC3M); Madrid Spain

5. Regenerative Medicine Unit; Basic Research Department; Centro de Investigaciones Energéticas; Medioambientales y Tecnológicas (CIEMAT); Madrid Spain

6. Molecular Oncology Unit; Basic Research Department; Centro de Investigaciones Energéticas; Medioambientales y Tecnológicas (CIEMAT); Madrid Spain

Funder

Science and Innovation Ministry of Spain

Comunidad de Madrid

IWT

Publisher

Wiley

Subject

Dermatology,Molecular Biology,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/exd.12321/fullpdf

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biotechnology in dermatology: present and future;Vestnik dermatologii i venerologii;2024-08-26

2. Exploring precision treatments in immune‐mediated inflammatory diseases: Harnessing the infinite potential of nucleic acid delivery;Exploration;2024-05-24

3. RNA-Based Antipsoriatic Gene Therapy: An Updated Review Focusing on Evidence from Animal Models;Drug Design, Development and Therapy;2024-04

4. Where should siRNAs go: applicable organs for siRNA drugs;Experimental & Molecular Medicine;2023-07-10

5. Small interfering RNA-based nanotherapeutics for treating skin-related diseases;Expert Opinion on Drug Delivery;2023-04-25